FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288010038> ?p ?o ?g. }

• W4288010038 abstract "Sodium-glucose cotransporter-2 (SGLT2) inhibitors are oral diabetes medications that enhance the excretion of glucose by preventing the renal proximal tubules from reabsorbing glucose, which lowers glucose levels in plasma. Currently, studies have shown that SGLT2 inhibitors have beneficial impacts on cardiovascular outcomes, but their effect varies between the individual SGLT2 inhibitors. Thus, the current meta-analysis was conducted to compare the efficacy of dapagliflozin and empagliflozin in preventing cardiovascular events in patients with type 2 diabetes. The current meta-analysis was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guidelines. A search of studies comparing cardiovascular events between dapagliflozin and empagliflozin in patients with type 2 diabetes published up to 1 July 2022 was done by two reviewers independently on PubMed, Embase and Cumulated Index to Nursing and Allied Health Literature (CINAHIL). The pre-specified primary endpoints were cardiovascular death, stroke, myocardial infarction and heart failure. Overall four studies were included in this meta-analysis. No significant difference was found in the incidence of myocardial infarction (risk ratio (RR)=0.81, 95% confidence interval (CI): 0.60-1.09), heart failure (RR=0.76, 95% CI: 0.56-1.04), cardiovascular mortality (RR=0.46, 95% CI: 0.18-1.20) and stroke (RR=1.07, 95% CI: 0.84-1.38) between dapagliflozin and empagliflozin. Results have shown that the risk of developing stroke, heart failure, myocardial infarction and cardiovascular death were not significantly different in the two groups." @default.
• W4288010038 created "2022-07-26" @default.
• W4288010038 creator A5001036201 @default.
• W4288010038 creator A5004685764 @default.
• W4288010038 creator A5014885735 @default.
• W4288010038 creator A5041425526 @default.
• W4288010038 creator A5062829105 @default.
• W4288010038 creator A5070181488 @default.
• W4288010038 creator A5078390548 @default.
• W4288010038 creator A5080863228 @default.
• W4288010038 date "2022-07-26" @default.
• W4288010038 modified "2023-09-26" @default.
• W4288010038 title "Comparison of Cardiovascular Outcomes Between Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes: A Meta-Analysis" @default.
• W4288010038 cites W2068250128 @default.
• W4288010038 cites W2096409056 @default.
• W4288010038 cites W2116475791 @default.
• W4288010038 cites W2128219379 @default.
• W4288010038 cites W2146264128 @default.
• W4288010038 cites W2147663252 @default.
• W4288010038 cites W2287058651 @default.
• W4288010038 cites W2618318327 @default.
• W4288010038 cites W2626446274 @default.
• W4288010038 cites W2749591576 @default.
• W4288010038 cites W2789703627 @default.
• W4288010038 cites W2790694951 @default.
• W4288010038 cites W2894993577 @default.
• W4288010038 cites W2895533920 @default.
• W4288010038 cites W2975677680 @default.
• W4288010038 cites W2976129020 @default.
• W4288010038 cites W2992022999 @default.
• W4288010038 cites W3153561131 @default.
• W4288010038 cites W3185500705 @default.
• W4288010038 cites W4212810717 @default.
• W4288010038 cites W4220777155 @default.
• W4288010038 cites W4253996779 @default.
• W4288010038 cites W4280507712 @default.
• W4288010038 cites W4281569134 @default.
• W4288010038 doi "https://doi.org/10.7759/cureus.27277" @default.
• W4288010038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36039257" @default.
• W4288010038 hasPublicationYear "2022" @default.
• W4288010038 type Work @default.
• W4288010038 citedByCount "0" @default.
• W4288010038 crossrefType "journal-article" @default.
• W4288010038 hasAuthorship W4288010038A5001036201 @default.
• W4288010038 hasAuthorship W4288010038A5004685764 @default.
• W4288010038 hasAuthorship W4288010038A5014885735 @default.
• W4288010038 hasAuthorship W4288010038A5041425526 @default.
• W4288010038 hasAuthorship W4288010038A5062829105 @default.
• W4288010038 hasAuthorship W4288010038A5070181488 @default.
• W4288010038 hasAuthorship W4288010038A5078390548 @default.
• W4288010038 hasAuthorship W4288010038A5080863228 @default.
• W4288010038 hasBestOaLocation W42880100381 @default.
• W4288010038 hasConcept C126322002 @default.
• W4288010038 hasConcept C127413603 @default.
• W4288010038 hasConcept C134018914 @default.
• W4288010038 hasConcept C164705383 @default.
• W4288010038 hasConcept C207103383 @default.
• W4288010038 hasConcept C2775887513 @default.
• W4288010038 hasConcept C2777180221 @default.
• W4288010038 hasConcept C2777422806 @default.
• W4288010038 hasConcept C2778198053 @default.
• W4288010038 hasConcept C2780645631 @default.
• W4288010038 hasConcept C44249647 @default.
• W4288010038 hasConcept C500558357 @default.
• W4288010038 hasConcept C555293320 @default.
• W4288010038 hasConcept C71924100 @default.
• W4288010038 hasConcept C78519656 @default.
• W4288010038 hasConcept C82789193 @default.
• W4288010038 hasConcept C95190672 @default.
• W4288010038 hasConceptScore W4288010038C126322002 @default.
• W4288010038 hasConceptScore W4288010038C127413603 @default.
• W4288010038 hasConceptScore W4288010038C134018914 @default.
• W4288010038 hasConceptScore W4288010038C164705383 @default.
• W4288010038 hasConceptScore W4288010038C207103383 @default.
• W4288010038 hasConceptScore W4288010038C2775887513 @default.
• W4288010038 hasConceptScore W4288010038C2777180221 @default.
• W4288010038 hasConceptScore W4288010038C2777422806 @default.
• W4288010038 hasConceptScore W4288010038C2778198053 @default.
• W4288010038 hasConceptScore W4288010038C2780645631 @default.
• W4288010038 hasConceptScore W4288010038C44249647 @default.
• W4288010038 hasConceptScore W4288010038C500558357 @default.
• W4288010038 hasConceptScore W4288010038C555293320 @default.
• W4288010038 hasConceptScore W4288010038C71924100 @default.
• W4288010038 hasConceptScore W4288010038C78519656 @default.
• W4288010038 hasConceptScore W4288010038C82789193 @default.
• W4288010038 hasConceptScore W4288010038C95190672 @default.
• W4288010038 hasLocation W42880100381 @default.
• W4288010038 hasLocation W42880100382 @default.
• W4288010038 hasLocation W42880100383 @default.
• W4288010038 hasOpenAccess W4288010038 @default.
• W4288010038 hasPrimaryLocation W42880100381 @default.
• W4288010038 hasRelatedWork W2807204184 @default.
• W4288010038 hasRelatedWork W2903890959 @default.
• W4288010038 hasRelatedWork W3104942557 @default.
• W4288010038 hasRelatedWork W3143290529 @default.
• W4288010038 hasRelatedWork W3179513936 @default.
• W4288010038 hasRelatedWork W3208638507 @default.
• W4288010038 hasRelatedWork W4210427521 @default.
• W4288010038 hasRelatedWork W4225666519 @default.
• W4288010038 hasRelatedWork W4237238868 @default.

• next